Lavipharm SA LAVI-GR:Athens Stock Exchange

*Data is delayed | EUR
Last | 02/26/21 EET
0.458quote price arrow down-0.002 (-0.43%)
Volume
6,924
52 week range
0.40 - 0.50

...

Loading . . .

KEY STATS

  • Open0.43
  • Day High0.458
  • Day Low0.43
  • Prev Close0.46
  • 52 Week High0.50
  • 52 Week High Date01/25/21
  • 52 Week Low0.40
  • 52 Week Low Date02/04/21
  • Market Cap28.36M
  • Shares Out51.08M
  • 10 Day Average Volume3,944.83
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • 1 Year % Change69.63

RATIOS/PROFITABILITY

  • EPS (TTM)0.13
  • P/E (TTM)3.52
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Lavipharm SA News

There is no recent news for this security.

Latest LAVI-GR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm...
Athanasios Lavidas
Chairman
Dimitra Tsomokou
Chief Financial Officer
Vasileios Vasilakopoulos
Chief Information Officer
Panagiotis Pavlou
Chief Accounting Officer
Spyridon Fotinos
Executive Vice President
Address
Agias Marinas Street, Peania
PO Box 59
Athina
190 02
Greece